// App-Quantinova.ai

3139 : Full Dose Treosulfan Based Reduced Toxicity Conditioning Regimen in Allogeneic Stem Cell Transplantation: Results in 123 Patients.

Researchers

Presenter

  • Roberto Crocchiolo

Principal Investigators

  • Carlo Messina

  • Consuelo Corti

  • Massimo Bernardi

  • Chiara Bonini

  • Fabio Ciceri

  • Jacopo Peccatori

  • Fabio Giglio

  • Alessandra Forcina

  • Sara Mastaglio

  • Maria Teresa Lupo Stanghellini

  • Andrea Assanelli

  • Salvatore Gattillo

  • Katharina Fleischhauer

  • Magda Marcatti

Medical Centers

  • Pathology Unit, San Raffaele H. Scientific Institute, Milano, Italy

  • Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy

  • Hematology and Bone Marrow Transplant Unit, San Raffaele Hospital, Milano, Italy

  • Cancer Immunotherapy and Gene Therapy Program, IRCCS H San Raffaele, Milan, Italy

  • San Raffaele Scientific Institute, Milan, Italy

  • Institut Paoli-Calmettes, Marseille, France

Locations

  • France

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Myeloid neoplasms

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Lymphomas

  • Graft-versus-host disease

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 34

Drug/Treatment

  • Cyclosporine A

  • ATG-F

  • Cyclosporine eent

  • Methotrexate

  • fludarabine tablet

  • Ovastat

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved